Condition

Primary Progressive Aphasia

ClinicalTrials.gov condition label

Clinical trials20

Recruiting4

Common interventions25

Lead sponsors shown14

Clinical trials

20 shown

Communication Bridge 3 StudyNCT06191198 · 2024-08-23

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive AphasiaNCT06511752 · 2024-05-21

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative ModelingNCT06529744 · 2023-11-11

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive AphasiaNCT05741853 · 2023-05-01

Communication Bridge Pilot StudyNCT06211374 · 2024-06-28

ACTIVE_NOT_RECRUITING

Home-based tDCS in Frontotemporal Dementia or Alzheimer's DiseaseNCT05978804 · 2023-08-10

Speech-Language Treatment With Remotely Supervised Transcranial Direct Current Stimulation in Primary Progressive AphasiaNCT05901233 · 2023-07-10

ENROLLING_BY_INVITATION

Long-term Effect of TMS in Primary Progressive AphasiaNCT05842473 · 2023-02-01

A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931NCT05730023 · 2023-02-01

Identification of Graphic Markers of Neurocognitive Disorders (MG)NCT05537688 · 2022-06-27

Better Living With Non-memory-led DementiaNCT05525377 · 2022-06-21

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric DisordersNCT04939818 · 2021-06-14

CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)NCT05697380 · 2021-06-01

Network Modulation in Alzheimer's DiseaseNCT04045990 · 2018-09-01

Florbetaben PET Imaging in PPANCT04720001 · 2018-08-23

Communication Bridge 2NCT03371706 · 2018-04-03

More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseNCT03076671 · 2017-03-01

Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural NetworksNCT03153371 · 2016-04-04

Clinical Evaluation of Florbetapir in Primary Progressive AphasiaNCT04726527 · 2012-03-15

Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory CenterNCT01465360 · 2011-11-01

Common interventions

Communication Bridge™BEHAVIORAL3 Evidence-Based Impairment FocusedBEHAVIORAL2 Lexical Retrieval Training (LRT)BEHAVIORAL2 Active tDCSDEVICE1 Active tDCS (tDCS) on DLPFCDEVICE1 Better living with non-memory led dementia courseBEHAVIORAL1 Communication BridgeBEHAVIORAL1 Computerized Cognitive TrainingOTHER1 Florbetaben F18DRUG1 Florbetapir F 18DRUG1 Identification of Graphic MarkersBEHAVIORAL1 individualized language trainingBEHAVIORAL1 Language therapyBEHAVIORAL1 Palliative CareBEHAVIORAL1 PETDEVICE1 Placebo tDCSDEVICE1 Positron Emission TomographyDEVICE1 Psychosocial educational, support group and implementation of strategiesBEHAVIORAL1 Remotely supervised sham tDCS (RS-sham-tDCS)DEVICE1 Remotely supervised Transcranial Direct Current Stimulation (RS-tDCS)DEVICE1 repetitive transcranial magnetic stimulation (rTMS)DEVICE1 Transcranial Magnetic Stimulation (active)DEVICE1 Transcranial Magnetic Stimulation (sham)DEVICE1 Video Implemented Script Training in Aphasia (VISTA)BEHAVIORAL1 Video-Implemented Script Training for Aphasia (VISTA)BEHAVIORAL1

Leading sponsors

University of Chicago6 University of Texas at Austin2 Brigham and Women's Hospital1 Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal1 Exonhit1 Hospital San Carlos, Madrid1 IRCCS Centro San Giovanni di Dio Fatebenefratelli1 Johns Hopkins University1 Novoic Limited1 Stephanie Grasso1 University College, London1 University Health Network, Toronto1 University of California, Los Angeles1 University of Colorado, Denver1

Trial status mix

COMPLETED12

RECRUITING4

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

TERMINATED1

UNKNOWN1

Phase mix

NA11

EARLY_PHASE11

PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.